Study protocol for a randomized controlled trial using VISIONARY, a dichoptic Gabor patch video game, to improve visual function in children with amblyopia

Author:

Pérez-Benito Maria1,Calderón-González Teresa2,Álvarez-Martín Esther1,Martín-González Santiago3,Portela-Camino Juan A.4

Affiliation:

1. Servicio de Oftalmología del Hospital de Mérida

2. Centro OPTO Terapia Visual

3. Universidad de Oviedo

4. Clínica Begira

Abstract

Abstract Background: Conventional treatment for amblyopia, involving occlusion and penalization of the dominant eye, does not always lead to effective outcomes and is associated with a high risk of recurrence and non-compliance. In this article, we present a protocol for a randomized controlled trial to evaluate the safety and clinical efficacy of Visionary, a novel computer-based therapy that uses dichoptic Gabor patches and band-filtered noise to treat amblyopia in the patient’s home. Methods: Our aim is to recruit a total of 120 children with amblyopia, aged 4–12 years, from the Paediatric Ophthalmology Unit at the Merida Hospital in Badajoz (Spain). The children will be divided into two groups according to whether or not they have previously undergone treatment involving occlusion or penalization of the dominant eye: 60 participants with no history of occlusion or penalization treatment will be assigned to Group A (GA), while Group B (GB) will consist of 60 participants who have previously received treatment with an occlusion dose > 32 weeks in mild or moderate amblyopia or > 48 weeks in severe amblyopia. In GA, the participants will be randomly assigned to either an experimental subgroup (GA-E) or a control subgroup (GA-C). Members of the GA-E group will be prescribed home therapy using computer-based exercises (Visionary); members of the GA-C group will be prescribed occlusion according to Pediatric Eye Disease Investigation Group (PEDIG) protocols. In GB, all participants will receive occlusion according to PEDIG protocols, and all will be prescribed home therapy using Visionary. In the experimental subgroup (GB-E), the computer will adjust the training spatial frequency of the Gabor patch, taking into account the user’s visual acuity (VA); while in the control subgroup (GB-C), the spatial frequency will remain low, irrespective of the patient’s VA. Visual function assessments will be carried out prior to the intervention and every three weeks thereafter; changes in best corrected visual acuity (BCVA) at distance will be the primary outcome measure under consideration. Stereoacuity and patient compliance will also be assessed. Discussion: The Visionary system based on dichoptic Gabor patches was originally conceived as a serious game to provide vision training to amblyopic children by combining the concepts of perceptual learning, dichoptic training, and gamification in the home environment. We hope that this novel approach may lead to greater improvements in vision performance in amblyopic children, as a substitute for occlusion treatment in novel amblyopia or as an adjunct treatment option in persistent amblyopia. Trial registration: This protocol was registered with ClinicalTrials.gov (NCT06150391) on 29th of November 2023.

Publisher

Research Square Platform LLC

Reference47 articles.

1. Ciuffreda KJ, Levi DM, Selenow A. Amblyopia: Basic and Clinical Aspects. Butterworth-Heinemann; 1991.

2. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis;Fu Z;Br J Ophthalmol,2020

3. The Amblyopia Treatment Studies: Implications for Clinical Practice;Chen AM;Adv Ophthalmol Optom,2016

4. Amblyopia and binocular vision;Birch EE;Prog Retin Eye Res,2013

5. Treatment outcomes for amblyopia using PEDIG amblyopia protocols: a retrospective study of 877 cases;Buckle M;J AAPOS,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3